Event Newsletter

Spindiag GmbH

  • Medical Technology/Devices/Equipment
  • About

    Spindiag GmbH, based in Freiburg/Breisgau, Germany, was founded in 2016 by a team of internationally renowned experts in the fields of microfluidics, lab-on-a-chip technology, and life sciences. Based on proprietary microfluidic technology developed at Hahn-Schickard and the University of Freiburg, Spindiag advanced the technology and implemented the fully automated Rhonda system as a sustainable platform for infection control and registered the CE-IVD mark for a PCR-based rapid COVID-19 test for use at the point of care. Since its foundation, the company has raised a total of EUR 24.9 million (USD 27.1 million) in four financing rounds for product development and preparation for market entry. Spindiag’s innovative technology has won several prizes awarded by experts from the healthcare industry, including the CODE_n-Contest by B. Braun and the Health-i Award by Techniker Krankenkasse and Handelsblatt. The company is EN ISO 13485 certified. Rhonda is a registered trademark of Spindiag GmbH.